{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T04:21:05Z","timestamp":1790742065548,"version":"4.1.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,19]],"date-time":"2023-03-19T00:00:00Z","timestamp":1679184000000},"content-version":"am","delay-in-days":322,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100010485","name":"Japan Student Services Organization","doi-asserted-by":"publisher","award":["UTB1817401008"],"award-info":[{"award-number":["UTB1817401008"]}],"id":[{"id":"10.13039\/501100010485","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["21jm0210062h0004"],"award-info":[{"award-number":["21jm0210062h0004"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["18J00112"],"award-info":[{"award-number":["18J00112"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.leukres.2022.106826","type":"journal-article","created":{"date-parts":[[2022,3,12]],"date-time":"2022-03-12T10:57:22Z","timestamp":1647082642000},"page":"106826","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Midkine inhibitor (iMDK) induces apoptosis of primary effusion lymphoma via G2\/M cell cycle arrest"],"prefix":"10.1016","volume":"116","author":[{"given":"Mikinori","family":"Ueno","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryusho","family":"Kariya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sittithumcharee","family":"Gunya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kodcharat","family":"Cheevapruk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seiji","family":"Okada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.leukres.2022.106826_bib1","doi-asserted-by":"crossref","first-page":"65","DOI":"10.5582\/irdr.2014.01010","article-title":"Current status of treatment for primary effusion lymphoma","volume":"3","author":"Okada","year":"2014","journal-title":"Intractable Rare Dis. Res."},{"key":"10.1016\/j.leukres.2022.106826_bib2","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1182\/blood.V88.2.645.bloodjournal882645","article-title":"Primary effusion lymphoma: a distinct clinicopathologic entity associated with the Kaposi\u2019s sarcoma-associated herpes virus","volume":"88","author":"Nador","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2022.106826_bib3","doi-asserted-by":"crossref","first-page":"19625","DOI":"10.1074\/jbc.272.31.19625","article-title":"A Kaposi\u2019s sarcoma-associated herpesvirus-encoded cytokine homolog (vIL-6) activates signaling through the shared gp130 receptor subunit","volume":"272","author":"Molden","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.leukres.2022.106826_bib4","doi-asserted-by":"crossref","first-page":"3102","DOI":"10.1158\/1078-0432.CCR-04-1857","article-title":"Inhibition of phosphatidylinositol 3\u2032-kinase\/Akt signaling promotes apoptosis of primary effusion lymphoma cells","volume":"11","author":"Uddin","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.leukres.2022.106826_bib5","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/36606","article-title":"Herpes viral cyclin\/Cdk6 complexes evade inhibition by CDK inhibitor proteins","volume":"390","author":"Swanton","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.leukres.2022.106826_bib6","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1007\/s12185-019-02668-0","article-title":"The current state of human immunodeficiency virus-associated lymphoma in Japan: a nationwide retrospective study of the Japanese society of hematology blood disease registry","volume":"110","author":"Hagiwara","year":"2019","journal-title":"Int. J. Hematol."},{"key":"10.1016\/j.leukres.2022.106826_bib7","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1016\/S0006-291X(88)80505-9","article-title":"cDNA cloning and sequencing of a new gene intensely expressed in early differentiation stages of embryonal carcinoma cells and in mid-gestation period of mouse embryogenesis","volume":"151","author":"Kadomatsu","year":"1988","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.leukres.2022.106826_bib8","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1093\/oxfordjournals.jbchem.a003231","article-title":"Midkine and pleiotrophin: Two related proteins involved in development, survival, inflammation and tumorigenesis","volume":"132","author":"Muramatsu","year":"2002","journal-title":"J. Biochem."},{"key":"10.1016\/j.leukres.2022.106826_bib9","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1038\/s41388-019-1124-8","article-title":"Midkine (MDK) growth factor: a key player in cancer progression and a promising therapeutic target","volume":"39","author":"Filippou","year":"2020","journal-title":"Oncogene"},{"key":"10.1016\/j.leukres.2022.106826_bib10","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1158\/2159-8290.CD-20-0789","article-title":"Modes of regulated cell death in cancer","volume":"11","author":"Koren","year":"2021","journal-title":"Cancer Discov."},{"key":"10.1016\/j.leukres.2022.106826_bib11","doi-asserted-by":"crossref","first-page":"410","DOI":"10.2183\/pjab.86.410","article-title":"Midkine, a heparin-binding cytokine with multiple roles in development, repair and diseases","volume":"86","author":"Muramatsu","year":"2010","journal-title":"Proc. Jpn. Acad. Ser. B."},{"key":"10.1016\/j.leukres.2022.106826_bib12","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1111\/j.1349-7006.2003.tb01494.x","article-title":"Preoperative serum midkine concentration is a prognostic marker for esophageal squamous cell carcinoma","volume":"94","author":"Shimada","year":"2003","journal-title":"Cancer Sci."},{"key":"10.1016\/j.leukres.2022.106826_bib13","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0071093","article-title":"Inhibition of the growth factor MDK\/Midkine by a novel small molecule compound to treat non-small cell lung cancer","volume":"8","author":"Hao","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.leukres.2022.106826_bib14","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.yexcr.2015.03.019","article-title":"A novel PI3K inhibitor iMDK suppresses non-small cell lung cancer cooperatively with a MEK inhibitor","volume":"335","author":"Ishida","year":"2015","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.leukres.2022.106826_bib15","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.3390\/cancers12092402","article-title":"Midkine is a potential therapeutic target of tumorigenesis, angiogenesis, and metastasis in non-small cell lung cancer","volume":"12","author":"Shin","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.leukres.2022.106826_bib16","first-page":"2775","article-title":"Novel midkine inhibitor iMDK inhibits tumor growth and angiogenesis in oral squamous cell carcinoma","volume":"36","author":"Masui","year":"2016","journal-title":"Anticancer Res."},{"key":"10.1016\/j.leukres.2022.106826_bib17","doi-asserted-by":"crossref","first-page":"415","DOI":"10.3109\/10428190009089442","article-title":"Midkine expression in Reed-sternberg cells of Hodgkin\u2019s disease","volume":"37","author":"Kato","year":"2000","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.leukres.2022.106826_bib18","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1111\/bph.12419","article-title":"Midkine as a regular of B cell survival in health and diseases","volume":"171","author":"Cohen","year":"2014","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.leukres.2022.106826_bib19","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1007\/s12185-013-1339-3","article-title":"Establishment of a CD4-positive cell line from an AIDS-related primary effusion lymphoma","volume":"97","author":"Goto","year":"2013","journal-title":"Int. J. Hematol."},{"key":"10.1016\/j.leukres.2022.106826_bib20","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1002\/(SICI)1096-9071(199908)58:4<394::AID-JMV12>3.0.CO;2-H","article-title":"Establishing and characterizing a CD30-positive cell line harboring HHV-8 from a primary effusion lymphoma","volume":"58","author":"Katano","year":"1999","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.leukres.2022.106826_bib21","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.canlet.2013.08.045","article-title":"HIV protease inhibitor Lopinavir induces apoptosis of primary effusion lymphoma cells via suppression of NF-\u03baB pathway","volume":"342","author":"Kariya","year":"2014","journal-title":"Cancer Lett."},{"key":"10.1016\/j.leukres.2022.106826_bib22","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1158\/1535-7163.MCT-17-1108","article-title":"Engaging anaphase catastrophe mechanisms to eradicate aneuploid cancers","volume":"17","author":"Kawakami","year":"2018","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.leukres.2022.106826_bib23","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1158\/2159-8290.CD-20-0789","article-title":"Modes of regulated cell death in cancer","volume":"11","author":"Koren","year":"2021","journal-title":"Cancer Discov."},{"key":"10.1016\/j.leukres.2022.106826_bib24","doi-asserted-by":"crossref","first-page":"2871","DOI":"10.1182\/blood.V94.8.2871.420k25_2871_2879","article-title":"Involvement of interleukin-10 (IL-10) and viral IL-6 in the spontaneous growth f Kaposi\u2019s sarcoma herpesvirus-associated infected primary effusion lymphoma cells","volume":"94","author":"Jones","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2022.106826_bib25","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1128\/MCB.15.1.345","article-title":"Effects of phosphorylation by CAK on cyclin binding by CDC2 and CDK2","volume":"15","author":"Desai","year":"1995","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.leukres.2022.106826_bib26","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1093\/carcin\/bgy039","article-title":"Bufalin inhibits human breast cancer tumorigenesis by inducing cell death through the ROS-mediated RIP1\/RIP3\/PARP-1 pathways","volume":"39","author":"Li","year":"2018","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.leukres.2022.106826_bib27","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1182\/blood-2018-03-791426","article-title":"Biology and management of primary effusion lymphoma","volume":"132","author":"Shimada","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2022.106826_bib28","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1182\/blood.V96.7.2537.h8002537_2537_2542","article-title":"Inhibition of NF-\u03baB induces apoptosis of KSHV-infected primary effusion lymphoma cells","volume":"96","author":"Keller","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2022.106826_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2021.153545","article-title":"Cucurbitacin B induces apoptosis of primary effusion lymphoma via disruption of cytoskeletal organization","volume":"85","author":"Ueno","year":"2021","journal-title":"Phytomedicine"},{"key":"10.1016\/j.leukres.2022.106826_bib30","article-title":"Comparative study of human hematopoietic cell engraftment in Balb\/c and C57BL\/6 strain Rag-2\/Jak3 double deficient mice","volume":"2011","author":"Ono","year":"2011","journal-title":"J. Biomed. Biotechnol."}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212622000522?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212622000522?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T01:01:43Z","timestamp":1758934903000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212622000522"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":30,"alternative-id":["S0145212622000522"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2022.106826","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Midkine inhibitor (iMDK) induces apoptosis of primary effusion lymphoma via G2\/M cell cycle arrest","name":"articletitle","label":"Article Title"},{"value":"Leukemia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.leukres.2022.106826","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106826"}}